| 000 | 00921 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250514071128.0 | ||
| 264 | 0 | _c20030904 | |
| 008 | 200309s 0 0 eng d | ||
| 022 | _a1369-7056 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHovinga, Collin A | |
| 245 | 0 | 0 |
_aSPM-927 (Schwarz Pharma). _h[electronic resource] |
| 260 |
_bIDrugs : the investigational drugs journal _cMay 2003 |
||
| 300 |
_a479-85 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAmides _xchemistry |
| 650 | 0 | 4 |
_aAnalgesics _xchemistry |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticonvulsants _xchemistry |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPropane _xanalogs & derivatives |
| 650 | 0 | 4 |
_aTechnology, Pharmaceutical _xlegislation & jurisprudence |
| 773 | 0 |
_tIDrugs : the investigational drugs journal _gvol. 6 _gno. 5 _gp. 479-85 |
|
| 999 |
_c12574798 _d12574798 |
||